association between health care provider (hcp)-assessed ecog performance status (ps) and overall survival, and objectively measure of physical activity (pa) levels in advance-cancer patients"

Conditions: Malignant Head and Neck Neoplasm; Malignant Neoplasm; Metastatic Malignant Neoplasm in the Neck; Metastatic Malignant Neoplasm in the Uterine Cervix; Pancreatic Adenocarcinoma; Pancreatic Neuroendocrine Carcinoma; Recurrent Colorectal Carcinoma; Stage I Colorectal Cancer AJCC v6 and v7; Stage I Hypopharyngeal Carcinoma AJCC v7; Stage I Major Salivary Gland Cancer AJCC v7; Stage I Nasopharyngeal Carcinoma AJCC v7; Stage I Oral Cavity Cancer AJCC v6 and v7; Stage I Oropharyngeal Carcinoma AJCC v6 and v7; Stage II Colorectal Cancer AJCC v7; Stage II Hypopharyngeal Carcinoma AJCC v6 and v7; Stage II Major Salivary Gland Cancer AJCC v7; Stage II Nasopharyngeal Carcinoma AJCC v7; Stage II Oral Cavity Cancer AJCC v6 and v7; Stage II Oropharyngeal Carcinoma AJCC v6 and v7; Stage IIA Colorectal Cancer AJCC v7; Stage IIB Colorectal Cancer AJCC v7; Stage IIC Colorectal Cancer AJCC v7; Stage III Colorectal Cancer AJCC v7; Stage III Hypopharyngeal Carcinoma AJCC v7; Stage III Laryngeal Cancer AJCC v6 and v7; Stage III Major Salivary Gland Cancer AJCC v7; Stage III Nasopharyngeal Carcinoma AJCC v7; Stage III Oral Cavity Cancer AJCC v6 and v7; Stage III Oropharyngeal Carcinoma AJCC v7; Stage IIIA Colorectal Cancer AJCC v7; Stage IIIB Colorectal Cancer AJCC v7; Stage IIIC Colorectal Cancer AJCC v7; Stage IV Colorectal Cancer AJCC v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVA Hypopharyngeal Carcinoma AJCC v7; Stage IVA Laryngeal Cancer AJCC v7; Stage IVA Major Salivary Gland Cancer AJCC v7; Stage IVA Nasopharyngeal Carcinoma AJCC v7; Stage IVA Oral Cavity Cancer AJCC v6 and v7; Stage IVA Oropharyngeal Carcinoma AJCC v7; Stage IVB Colorectal Cancer AJCC v7; Stage IVB Hypopharyngeal Carcinoma AJCC v7; Stage IVB Laryngeal Cancer AJCC v7; Stage IVB Major Salivary Gland Cancer AJCC v7; Stage IVB Nasopharyngeal Carcinoma AJCC v7; Stage IVB Oral Cavity Cancer AJCC v6 and v7; Stage IVB Oropharyngeal Carcinoma AJCC v7; Metastatic or Locally Unresectable Solid Tumor

Summary: the main goal of this phase of the study is to determine if objectively assessed physical activity (pa) levels in advanced-cancer patients are associated with health care provider (hcp)-assessed ecog performance status and overall survival. the purpose is to advance the evidence-base for incorporating objective assessment of physical activity (pa) in the context of performance status assessment in advanced cancer patients.

primary objectives: i. to explore the feasibility and acceptability in diverse samples of cancer patients of wireless collection and transmission of data for transfer into the open-source cyberinfrastructure (ci) called cyberinfrastructure for comparative effectiveness research (cycore). outline: patients are assigned to 1 of 4 arms. arm i (colorectal cancer patients) (closed to accrual as of 01/30/14): patients use two accelerometers, a blood pressure monitor, a heart rate monitor, a global positioning system (gps) device, and a smart phone that prompts patients to electronically answer questions about exercise and health-related symptoms and feelings. the devices are used for 5 consecutive days. after a 2 week period, patients resume use of the devices for an additional 5 days. arm ii (head and neck cancer patients) (closed to accrual as of 01/30/14): patients use two accelerometers, a blood pressure monitor, a weight scale, and a smart phone that prompts patients to electronically answer questions about diet and health-related symptoms. the devices are used for 5 consecutive days. after a 2 week period, patients resume use of the devices for an additional 5 days. arm iii (head and neck cancer patients) (closed to accrual as of 01/30/14): patients use a smart phone that prompts patients to electronically answer questions about diet, health-related symptoms, and swallowing exercises. patients also take video recordings of their neck while performing swallowing exercises. the device is used for 5 consecutive days. after a 2 week period, patients resume use of the device for an additional 5 days. arm iv (cancer survivors that are current/former smokers) (closed to accrual as of 01/30/14): patients use a carbon monoxide (co) monitor and a smart phone that prompts patients to electronically answer questions about smoking. patients also take video recordings of themselves while exhaling into the co monitor. the devices are used for 5 consecutive days. after a 2 week period, patients resume use of the devices for an additional 5 days. pancreatic cancer study (pcs): patients receive post-surgical wellness program consisting of physical activity, nutrition counseling, and daily monitoring (physical activity, weight, and self-reported data) for up to 7 months post-op. technological approach to performance status (taps) study: patients use two physical activity monitor devices, the wrist-worn device (fitbit) continuously and the actigraph during waking hours. patients use the devices for 7 consecutive days.

Eligibility criteria:
inclusion criteria: * diagnosis of any stage i - iv colorectal cancer or recurrent colorectal cancer (arm 1) * able to speak, read, and write in english (pre-pilot phase, arms 1-4) * able to provide informed consent (pre-pilot phase, arms 1-4, pcs study) * lives in the houston area (harris county or a contiguous county) (pre-pilot phase) * eastern cooperative oncology group (ecog) status of 0 - 2, or self-reports being up and about more than 50% of waking hours and able to provide self-care (arm 1) * diagnosis of any of the following cancers: stage 1-4b oropharyngeal, hypopharyngeal, nasopharyngeal, salivary gland or oral cavity; stage 3-4b laryngeal; any unknown primary head and neck cancer with cervical metastasis that will be addressed with treatment to bilateral necks and mucosa; or other head and neck cancers medically approved by one of our radiation oncology collaborating medical doctors (mds) (arms 2 and 3) * history of any cancer, other than non-melanoma skin cancer (arm 4) * admitted to being a current smoker or recent quitter upon admission to md anderson cancer center (mdacc) (arm 4) * has a valid home address and functioning home telephone number (arm 4) * lives in the houston or surrounding area, or resides in this same area during the time period that coincides with this study (arms 1-4) * patients who will undergo curative pancreatectomy for pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, or pancreatic cysts (malignant or benign) (pcs study) * fluent in english (pcs study) * must have telephone access and agree to engage with research personnel using telephone (pcs study) * diagnosis of a metastatic or locally unresectable solid tumor (taps study) * fluent in english (taps study) * age 18 years or older (taps study) * ecog performance status score between 0-3 (taps study) exclusion criteria: * major surgery in the past 8 weeks (arms 1 and 4) * self-reports hypertension that is not being monitored by a physician and is not being managed with either medication, observation, or lifestyle change (pre-pilot phase, arms 1-3) * overt cognitive difficulty demonstrated by not being clearly oriented to time or person or place (arms 1-4) * orthopedic, neurologic, or musculoskeletal disability that would interfere with the functional task of standing on a weight scale (pre-pilot phase, arm 2) * not currently receiving radiation treatment for a cancer listed in the arm-specific inclusion criteria (arms 2 and 3) * zubrod performance status \> 2, or self-reports either not being up and about more than 50% of waking hours or unable to provide self-care (arms 2 and 3) * currently receiving treatment for a cancer other than those listed in the arm-specific inclusion criteria (exception: the study does not exclude those receiving treatment for non-melanoma skin cancer) (arms 2 and 3) * history of current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g. dysphagia due to underlying neurogenic disorder) (arm 3 only) * active substance use disorder (diagnosed or strongly suspected) (arm 4) * currently enrolled in protocol 2014-0712 (pcs study) * no home access to internet (pcs study) * no home wifi connection (pcs study) * during clinician's pre-surgical evaluation, presents with high risk for non-therapeutic resection related to cancer diagnosis (pcs study) * underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (new york heart association functional class iii or iv) (pcs study) * recent fracture or acute musculoskeletal injury that precludes the ability to fully bear weight on all 4 limbs in order to participate in an exercise intervention (pcs study) * poorly-controlled pain with a self-reported pain score of 7/10 at the time of enrollment (pcs study) * myopathic or rheumatologic disease that impacts physical function (pcs study) * has a pacemaker or other internal medical device, or reports being pregnant (pcs study) * currently enrolled in protocol 2017-0198 (pcs study) * demonstration of overt cognitive difficulty as demonstrated by not being clearly oriented to time or person or place (taps study)